New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
14 Feb 2024
14 Feb 2024
Historique:
received:
06
01
2024
accepted:
29
01
2024
medline:
19
2
2024
pubmed:
19
2
2024
entrez:
19
2
2024
Statut:
epublish
Résumé
Malignant melanoma is the most invasive skin cancer with the highest risk of death. The inhibition of BRAF
Identifiants
pubmed: 38370458
doi: 10.1039/d4ra00157e
pii: d4ra00157e
pmc: PMC10870110
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5907-5925Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts of interest to declare.